Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucentis for Diabetic Macular Edema and Lipid Exudates
NCT02448446Phase 2Completed
- Sponsor
- South Coast Retina Center
- Start
- Aug 2015
- Primary completion
- May 2018
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in diabetic macular edema (DME), sponsored by South Coast Retina Center. Started Aug 2015; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02448446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448446.